Chalmers clears $3.3B Insignia buyout by CC Capital
Federal Treasurer Jim Chalmers has cleared the $3.3 billion acquisition of Insignia Financial (ASX:IFL) by US-based private equity firm CC Capital.

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.
Federal Treasurer Jim Chalmers has cleared the $3.3 billion acquisition of Insignia Financial (ASX:IFL) by US-based private equity firm CC Capital.
Anson Resources (ASX:ASN) concluded its initial exploration drilling programme at the Yellow Cat Uranium Vanadium Project.
Zenith Minerals (ASX:ZNC) has commenced a high-impact drilling programme at its Dulcie to Grow Project.
DroneShield (ASX:DRO) announces a major leadership transition as CEO Oleg Vornik steps down after a decade of record growth.
Talonx Resources (ASX:TXR) has mobilised for a 3,000-metre reverse circulation drilling programme.
The United States and Iran agreed to a two-week ceasefire on Tuesday evening following an urgent diplomatic intervention led by Pakistan, easing fears of an immediate escalation in the five-week conflict.
PriceSmart (NASDAQ:PSMT), the largest operator of membership warehouse clubs in Central America, the Caribbean, and Colombia, reported robust financial results for its second fiscal quarter ended February 28, 2026, on April 8, 2026.
Bed Bath & Beyond (NYSE:BBBY) announced on April 8, 2026, that it has signed a letter of intent to acquire the equity interests and substantially all assets of F9 Brands, a move designed to anchor the company’s new national home services ecosystem, Beyond Home Services.
Waters Corporation (NYSE:WAT) reached a significant regulatory milestone on April 8, 2026, with the U.S. Food and Drug Administration granting clearance for the Onclarity HPV Self-Collection Kit and approval for the associated assay for at-home use.
Bausch + Lomb (NYSE:BLCO), a leader in eye health, announced on April 8, 2026, that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Bi-Blade+ dual-port vitrectomy cutter and an advanced Adaptive Fluidics update for the Stellaris Elite® Vision Enhancement System.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy